Standard BioTools Inc.
LAB
$1.07
$0.000.00%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -86.03% | -64.53% | -40.99% | 31.14% | 60.73% |
| Total Depreciation and Amortization | 11.07% | 39.04% | 505.35% | 390.05% | 333.84% |
| Total Amortization of Deferred Charges | -- | -100.00% | -126.61% | -97.86% | -100.00% |
| Total Other Non-Cash Items | -57.23% | -74.73% | -83.36% | -98.41% | -81.90% |
| Change in Net Operating Assets | -1,380.58% | -897.69% | -161.93% | -36.51% | 87.26% |
| Cash from Operations | -231.40% | -196.35% | -106.15% | -18.25% | 51.56% |
| Capital Expenditure | -195.13% | -43.99% | 4.29% | 34.41% | 25.99% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 302.64% | -36.00% | -79.04% | 144.17% | 127.36% |
| Cash from Investing | 1,694.60% | 340.67% | 127.38% | 769.22% | 122.96% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2,933.70% | -1,033.49% | -- | -- | 69.54% |
| Issuance of Common Stock | 150.30% | 169.68% | 165.15% | -2.81% | -10.59% |
| Repurchase of Common Stock | -637.42% | -587.84% | -631.40% | -332.31% | -610.10% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 95.66% | -- |
| Cash from Financing | -1,407.06% | -708.08% | -922.19% | -111.41% | -102.95% |
| Foreign Exchange rate Adjustments | -2,408.82% | -342.02% | -68.75% | 96.62% | 108.42% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 490.01% | 583.59% | 89.01% | 108.35% | -156.43% |
